Stereotactic Microwave Ablation of Early-Stage Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts: A Matched Case–Control Study
CardioVascular and Interventional Radiology · 2026
DOI: 10.1007/s00270-026-04522-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, 2026. Verfasst von Liang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. Liang.Zhang@ukr.de. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Portasystemic Shunt, Transjugular Intrahepatic, Microwaves. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Regensburg.
Abstract (Originalsprache)
Purpose
To assess safety and outcomes of stereotactic CT-guided microwave ablation (MWA) for hepatocellular carcinoma (HCC) in patients with transjugular intrahepatic portosystemic shunts (TIPS) versus a matched control group without TIPS. Materials and Methods Retrospective matched case–control study of cirrhotic patients with HCC treated with stereotactic CT-guided MWA. TIPS patients were matched 1:1 to controls using hierarchical matching based on Child–Pugh class, number of treated tumors, MELD score, tumor diameter, and ablation date. Primary endpoints were primary technique efficacy (PTE), local tumor progression (LTP), 30-day complications, and 30-day all-cause mortality. Secondary endpoints were 12-month Kaplan–Meier estimates for progression-free survival (PFS), hepatic decompensation-free survival (HDFS), and overall survival (OS), compared using log-rank tests.
Results
46 patients (23 TIPS, 23 controls) with 62 index lesions were analyzed. PTE was achieved in 30/31 lesions (96.8%) in both groups. Among lesions with PTE, LTP occurred in 1/30 lesions (3.3%) in the TIPS group and 0/30 lesions (0%) in controls. Within 30 days, two major complications occurred in the TIPS group and one in the control group; no 30-day deaths occurred. Observed 12-month estimates did not differ significantly between groups for PFS (52.4% vs. 46.0%, p = 0.876), HDFS (71.8% vs. 76.9%, p = 0.519), or OS (91.1% vs. 90.0%, p = 0.903). Child–Pugh A was associated with higher HDFS than Child–Pugh B (95.8% vs. 50.2%, p = 0.001).
Conclusion
Stereotactic CT-guided MWA of early-stage HCC appears feasible in carefully selected patients with TIPS, warranting further evaluation in larger cohorts. Level of Evidence 3b.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. Liang.Zhang@ukr.de.
- Department of Radiology, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
Förderung
- Universitätsklinikum Regensburg
Zitieren
APA
Zhang, L., Strotzer, Q. D., Kupke, L. S., Mayr, V., Hiernickel, G. H., Brandenstein, M., Luerken, L., Jage, S., Scharf, G., Stroszczynski, C., & Einspieler, I. (2026). Stereotactic Microwave Ablation of Early-Stage Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts: A Matched Case–Control Study. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-026-04522-3
Vancouver
Zhang L, Strotzer QD, Kupke LS, Mayr V, Hiernickel GH, Brandenstein M, et al. Stereotactic Microwave Ablation of Early-Stage Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts: A Matched Case–Control Study. CardioVascular and Interventional Radiology. 2026. doi:10.1007/s00270-026-04522-3
BibTeX
@article{Zhang2026,
author = {Zhang, Liang and Strotzer, Quirin D and Kupke, Laura S and Mayr, Vinzenz and Hiernickel, Georg H and Brandenstein, Moritz and Luerken, Lukas and Jage, Simon and Scharf, Gregor and Stroszczynski, Christian and Einspieler, Ingo},
title = {Stereotactic Microwave Ablation of Early-Stage Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts: A Matched Case–Control Study},
journal = {CardioVascular and Interventional Radiology},
year = {2026},
doi = {10.1007/s00270-026-04522-3}
}
EUVIMED